• LAST PRICE
    0.8880
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.8820/ 1
  • Ask / Lots
    1.1000/ 5
  • Open / Previous Close
    --- / 0.8880
  • Day Range
    ---
  • 52 Week Range
    Low 0.6900
    High 1.6000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.903
TimeVolumeKRON
09:32 ET38910.8814
09:39 ET1000.9089
09:42 ET4030.91
09:46 ET1000.915
09:50 ET21000.915
09:57 ET18040.9134
10:08 ET1000.9094
10:09 ET3590.9
10:11 ET10000.9064
10:15 ET2000.9048
11:05 ET34420.8976
11:09 ET1000.9038
11:12 ET3000.9099
11:21 ET1000.8971
11:30 ET1000.8961
12:12 ET1000.904
12:17 ET1000.904
12:26 ET1000.904
12:39 ET45000.901075
12:46 ET2000.904
12:51 ET7760.8981
01:02 ET45000.8981
01:06 ET105000.9
01:15 ET129070.886
01:40 ET20000.88216
01:51 ET20000.8821
02:00 ET4400.8915
02:02 ET4440.898
02:05 ET54000.88822
02:12 ET19000.888
02:20 ET85110.900199
02:25 ET6000.9001
02:30 ET1000.9041
02:34 ET21000.9001
02:41 ET6720.8996
02:56 ET2290.8881
02:57 ET12620.888
02:59 ET1000.888
03:06 ET2000.888
03:08 ET6550.888
03:10 ET2000.888
03:12 ET5250.888
03:14 ET1000.888
03:15 ET25050.888
03:17 ET5000.888
03:19 ET32000.8884
03:21 ET31000.888423
03:24 ET3000.888
03:26 ET1000.888
03:28 ET2000.888
03:30 ET2000.888
03:32 ET1000.88805
03:33 ET3000.8881
03:35 ET3000.8888
03:39 ET1000.889
03:42 ET11260.888
03:44 ET3000.888
03:46 ET1000.888
03:48 ET12000.88805
03:50 ET6000.88805
03:51 ET5300.888
03:55 ET1000.8881
03:57 ET1210.888
04:00 ET86570.888
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKRON
Kronos Bio Inc
54.4M
-0.6x
---
United StatesKZR
Kezar Life Sciences Inc
54.7M
-0.6x
---
United StatesCUE
Cue Biopharma Inc
61.4M
-1.2x
---
United StatesLVTX
LAVA Therapeutics NV
42.1M
-1.8x
---
United StatesDYAI
Dyadic International Inc
57.1M
-8.7x
---
United StatesATRA
Atara Biotherapeutics Inc
66.1M
-0.5x
---
As of 2024-11-26

Company Information

Kronos Bio, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics that target the deregulated transcription that causes cancer and other serious diseases. It is developing KB-0742, its internally discovered oral cyclin dependent kinase 9 (CDK9) inhibitor, for the treatment of MYC-amplified and others transcriptionally addicted solid tumors. It has initiated the Phase 2 portion of its Phase 1/2 clinical trial for KB-0742. It is also developing KB-9558, which inhibits the lysine acetyltransferase (KAT) domain of p300, a critical node of the IRF4 TRN. IRF4 is a key transcription factor driver in multiple myeloma and KB-9558 selectively targets its activity. Its scientific focus is on developing medicines that target deregulated transcription, the hallmark of cancer and other serious diseases. Using its Small Molecule Microarray (SMM) platform or other approaches, it can generate and advance small molecule starting points into drug development candidates.

Contact Information

Headquarters
1300 S. El Camino Real, Suite 400SAN MATEO, CA, United States 94402
Phone
650-781-5200
Fax
302-636-5454

Executives

Non-Executive Independent Chairman of the Board
Arie Belldegrun
President, Chief Executive Officer, Director
Norbert Bischofberger
Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer
Deborah Knobelman
Senior Vice President - Corporate Operations and Legal
Allison Frisbee
Senior Vice President - Research and Development
Charles Lin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$54.4M
Revenue (TTM)
$9.9M
Shares Outstanding
60.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.83
EPS
$-1.44
Book Value
$2.70
P/E Ratio
-0.6x
Price/Sales (TTM)
5.5
Price/Cash Flow (TTM)
---
Operating Margin
-943.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.